Gemma Eminowicz1, Vasilis Rompokos2, Christopher Stacey2, Lisa Hall2, Mary McCormack2. 1. University College London Hospital, Department of Radiotherapy, United Kingdom. Electronic address: eminowicz@doctors.org.uk. 2. University College London Hospital, Department of Radiotherapy, United Kingdom.
Abstract
BACKGROUND: Advanced radiotherapy techniques reduce normal tissue dose by conforming closely to target volumes. In cervical cancer radiotherapy, organ filling affects clinical target volume (CTV; cervix, uterus) position. This study estimates the dosimetric effect of this primary CTV position variation during chemoradiation. METHODS/MATERIALS: Twice weekly cone-beam computed tomography (CBCT) images of ten patients undergoing cervical chemoradiation were retrospectively analysed. Primary CTV, bladder and rectum were delineated. RapidArc plans were created using 10-15mm CTV-PTV margins and dose delivered to CTV based on each CBCT position was calculated using a novel vector approach. Dose delivered along the central uterine, mid-uterus and cervix vectors were analysed as well as dose delivered to points at uterine tip, anterior mid-uterus and anterior cervix. Additional RapidArc plans were created for large planning bladder volume cases using the CTV acquired with bladder volume at 150-300cc. RESULTS: 105 scans for 10 patients were analysed. Vector analysis revealed CTV underdosing in certain cases. Below 95% average vector coverage was found for all three vectors in 2 cases and one vector in 1 case. Volumetric analysis revealed D99<95% in 48% of fractions. Patients with large planning bladder volumes (>300cc) demonstrated the largest variation. Replanning improved this coverage. The anterior mid-uterus point was least well-covered; median 98.7% dose, reducing to 91.4% in cases with large planning bladder volumes. Again, replanning significantly improved this. D99>95% was maintained in 93% of fractions when bladder volume was 50cc below to 150cc above planning volume compared to 24% of fractions if bladder volume was outside this range. Similarly, D95>95% was 100% versus 84%. CONCLUSION: Organ position variation detrimentally affected dose delivered to CTV including cervix. Large planning bladder volumes (>300cc) led to more variation. We recommend bladder volumes of 150-300cc at planning and a range of 50cc below to 150cc above planning for treatment.
BACKGROUND: Advanced radiotherapy techniques reduce normal tissue dose by conforming closely to target volumes. In cervical cancer radiotherapy, organ filling affects clinical target volume (CTV; cervix, uterus) position. This study estimates the dosimetric effect of this primary CTV position variation during chemoradiation. METHODS/MATERIALS: Twice weekly cone-beam computed tomography (CBCT) images of ten patients undergoing cervical chemoradiation were retrospectively analysed. Primary CTV, bladder and rectum were delineated. RapidArc plans were created using 10-15mm CTV-PTV margins and dose delivered to CTV based on each CBCT position was calculated using a novel vector approach. Dose delivered along the central uterine, mid-uterus and cervix vectors were analysed as well as dose delivered to points at uterine tip, anterior mid-uterus and anterior cervix. Additional RapidArc plans were created for large planning bladder volume cases using the CTV acquired with bladder volume at 150-300cc. RESULTS: 105 scans for 10 patients were analysed. Vector analysis revealed CTV underdosing in certain cases. Below 95% average vector coverage was found for all three vectors in 2 cases and one vector in 1 case. Volumetric analysis revealed D99<95% in 48% of fractions. Patients with large planning bladder volumes (>300cc) demonstrated the largest variation. Replanning improved this coverage. The anterior mid-uterus point was least well-covered; median 98.7% dose, reducing to 91.4% in cases with large planning bladder volumes. Again, replanning significantly improved this. D99>95% was maintained in 93% of fractions when bladder volume was 50cc below to 150cc above planning volume compared to 24% of fractions if bladder volume was outside this range. Similarly, D95>95% was 100% versus 84%. CONCLUSION: Organ position variation detrimentally affected dose delivered to CTV including cervix. Large planning bladder volumes (>300cc) led to more variation. We recommend bladder volumes of 150-300cc at planning and a range of 50cc below to 150cc above planning for treatment.
Authors: John Rodgers; Rosie Hales; Lee Whiteside; Jacqui Parker; Louise McHugh; Anthea Cree; Marcel van Herk; Ananya Choudhury; Peter Hoskin; Alan McWilliam; Cynthia L Eccles Journal: Br J Radiol Date: 2020-06-16 Impact factor: 3.039
Authors: Nina Boje Kibsgaard Jensen; Marianne Sanggaard Assenholt; Lars Ulrik Fokdal; Anne Vestergaard; Annette Schouboe; Eva Bruun Kjaersgaard; Annette Boejen; Lars Nyvang; Jacob Christian Lindegaard; Kari Tanderup Journal: Phys Imaging Radiat Oncol Date: 2018-12-20